Call us: + 31 (0)20 - 4350 580

Home > News > Newsletter

Newsletter

Oncology Highlights - June 2020

Oncology Highlights - June 2020
2 July 2020 - Oana Draghiciu PhD

Novel approaches personalized therapy AML, AML drug resistance, FDA and EMA drug approvals June 2020, oncology industry June 2020

Read more

Oncology Highlights - May 2020

Oncology Highlights - May 2020
3 June 2020 - Oana Draghiciu PhD, Jan-Hendrik Venhuizen MSc

Sensitizing brain metastases to immunotherapy, news and approvals from the industry and novel guidelines for accelerated COVID-19 treating/preventing products

Read more

Oncology Highlights - April 2020

Oncology Highlights - April 2020
6 May 2020 - Oana Draghiciu PhD, Jan-Hendrik Venhuizen MSc

Practical recommendations for cancer care management during the pandemic, news and approvals from the industry and final guidance from the FDA

Read more

We are ready to support you

We are ready to support you
9 April 2020 - CATO SMS

We know there are issues arising from the COVID-19 pandemic that may affect your clinical trial and cause delays. CATO SMS is here to support you! Learn more how we can help you move forward.

Read more

Oncology Highlights - March 2020

Oncology Highlights - March 2020
2 April 2020 - Oana Draghiciu PhD

The impact of COVID-19 on cancer patients, news and approvals from the industry and novel guidelines on clinical trial conduct as the pandemic spreads.

Read more

Oncology Highlights - February 2020

Oncology Highlights - February 2020
4 March 2020 - Oana Draghiciu PhD

Novel therapy with CAR-transduced NK cells, Pan-Cancer analysis of whole tumor genomes and news from the industry

Read more

Oncology Highlights - January 2020

Oncology Highlights - January 2020
5 February 2020 - Oana Draghiciu PhD

Diagnosis and grading of prostate cancer with artificial intelligence, first results with KRAS inhibitors, and news on FDA guidelines

Read more

Oncology Highlights - December 2019

Oncology Highlights - December 2019
7 January 2020 - Oana Draghiciu PhD

Three large acquisitions, CAR-T cell therapy for MCL and final approvals of 2019

Read more

Oncology Highlights - November 2019

Oncology Highlights - November 2019
9 December 2019 - Oana Draghiciu PhD

News on CRISPR gene editing and a promising therapy for high-risk AML

Read more

Oncology Highlights - October 2019

Oncology Highlights - October 2019
1 November 2019 - Oana Draghiciu PhD

Niraparib increases PFS in advanced ovarian cancer and ramucirumab and erlotinib increase PFS in metastatic NSCLC

Read more

Oncology Highlights - September 2019

Oncology Highlights - September 2019
1 October 2019 - Oana Draghiciu PhD

Tumor mutational burden not associated with pembrolizumab efficacy in NSCLC and insight in a new safe and potent anti-CD19 CAR T cell therapy

Read more

Oncology Highlights - August 2019

Oncology Highlights - August 2019
6 September 2019 - Oana Draghiciu PhD

Selection of TP53 missense mutation driven by a dominant-negative effect, neutral genetic drift as cause of long-term cancer evolution, infusions of humanized anti-CD19 and anti-BCMA CAR T cells are feasible

Read more

Oncology Highlights - July 2019

Oncology Highlights - July 2019
6 August 2019 - Oana Draghiciu PhD

Soft drinks and fruit juice associated with increased risk of cancer, enhanced CAR-T cell efficacy in solid tumors, Prolonged PFS in solid tumors with NEO-PV-01

Read more

Oncology Highlights - June 2019

Oncology Highlights - June 2019
5 July 2019 - Oana Draghiciu PhD

Astrocytes play role immunosuppression, TILs related to spatial distribution, FDA and EMA approvals, ASCO guidelines

Read more

Oncology Highlights - May 2019

Oncology Highlights - May 2019
6 June 2019 - Laurynas Navakauskas MSc

CRISPR FIH trial, Neo-neurogenesis in prostate cancer, CTC prospecting with HydroSeq (scRNA-seq), Industry updates, EMA and FDA approvals in May

Read more

Oncology Highlights - April 2019

Oncology Highlights - April 2019
6 May 2019 - Thom Sentner MSc

TAMs' role in cancer, zebrafish model for drug selection, M&A in April, EMA and FDA approvals in April

Read more

Oncology Highlights - March 2019

Oncology Highlights - March 2019
9 April 2019 - Yuva Oz MSc, Business Development

Brain-on-a-chip, upcoming CAR-T therapies, Flagship Pioneering, Tecentriq approval for SCLC and TNBC

Read more

Oncology Highlights - February 2019

Oncology Highlights - February 2019
1 March 2019 - Tim Koopman MSc., Business Developer

The Human Tumor Atlas Network (HTAN), barcoding single cells, FDA&EMA approvals, M&A oncology in February

Read more

Oncology Highlights - January 2019

Oncology Highlights - January 2019
6 February 2019 - Yuva Oz MSc., Business Development

Overriding the "don't eat me" signal, AI test predicts aggresive cancer, Lilly buys Loxo, FDA, EMA approvals and more

Read more

Oncology Highlights - December 2018

Oncology Highlights - December 2018
4 January 2019 - Yuva Oz MSc., Business Development

2018 year in review, mining the gold-DNA interactions, skin cells armored to fight cancer, IO market news, FDA's real world evidence program

Read more
1 2 3 next